Infant formula is a critical source of nutrition for babies, especially when breastfeeding is not an option. Parents rely on formula companies to ensure products are safe, nutritious, and free from harmful contaminants. Recent reports, however, have raised concerns about ByHeart infant formula, following a botulism outbreak linked to a milk powder ingredient. This article provides an in-depth look at the outbreak, FDA findings, and precautions parents should take.
Infant botulism is a rare but serious condition caused by bacteria Clostridium botulinum. This bacteria produces toxins that attack the nervous system, leading to muscle weakness, feeding difficulties, constipation, and in severe cases, respiratory failure. Babies under 12 months are particularly vulnerable because their digestive systems are not fully developed, making it easier for the bacteria to grow and release toxins in the intestines.
According to the Centers for Disease Control and Prevention (CDC), symptoms of infant botulism can appear gradually and include weak crying, decreased movement, poor feeding, and lethargy. Immediate medical attention is critical, as timely treatment with supportive care or botulism-specific therapy can prevent severe complications.
Federal health officials and the FDA have been investigating an outbreak of infant botulism linked to ByHeart formula. The outbreak affected 51 babies across 19 states in the United States, with cases reported since December 2023. The spike was first noticed in November 2023 when California health officials observed an unusual increase in infant botulism among babies who had consumed ByHeart formula.
ByHeart, a New York–based company, launched its formula in March 2022, marketing it as organic, grass-fed, and close to breast milk in nutritional quality. The product accounted for about 1% of the U.S. formula market, with approximately 200,000 cans sold per month at around $42 per can.
On January 23, 2026, the FDA reported finding Clostridium botulinum bacteria in two samples related to ByHeart formula. One sample came from an unopened can of the finished product, while the other was from organic whole milk powder used to manufacture the formula. Genetic testing showed that both samples matched bacteria found in a sick baby.
Additionally, the FDA found contamination in another batch of whole milk powder supplied to ByHeart, which also matched bacteria in a finished formula product. While these results are significant, the FDA cautioned that they are not yet conclusive, and the investigation is ongoing to determine the exact source of contamination.
ByHeart confirmed the findings, stating that the results suggest they are closer to identifying the root cause of the contamination. However, the company and federal authorities have not disclosed the milk powder supplier involved.
Initially, ByHeart recalled two lots of formula. Shortly afterward, the recall expanded to all products, as federal officials could not rule out contamination in any formula produced since the company’s launch. Company testing indicated that six out of 36 samples from three different lots contained botulism-causing bacteria.
Experts have criticized the lack of mandatory testing for harmful bacteria in infant formula. Some manufacturers voluntarily test ingredients and finished products, but there is currently no federal requirement to do so. Sarah Sorscher, director of regulatory affairs at the Center for Science in the Public Interest, emphasized the need for FDA-mandated testing to prevent future outbreaks.
Seattle food safety attorney Bill Marler, who represents more than 30 affected families, highlighted that responsibility remains with ByHeart. He noted that identifying contaminated milk powder does not absolve the company from legal or moral responsibility. Families affected by the outbreak may pursue legal action to seek compensation for medical costs, emotional distress, and other damages.
The outbreak raises broader questions about the regulation of infant formula in the United States. Currently, formula manufacturers must follow strict guidelines for nutritional content, but pathogen testing is often voluntary. Critics argue that mandatory testing for bacteria like Clostridium botulinum could prevent similar incidents and improve infant safety nationwide.
While investigations continue, parents and caregivers should remain vigilant. Some key precautions include:
ByHeart promoted its formula as organic and made with grass-fed whole milk, positioning itself as a premium alternative to traditional formulas. Many parents choose organic or specialty formulas because of perceived health benefits, environmental considerations, or dietary preferences.
However, the outbreak demonstrates that even premium products are not immune to contamination. Experts recommend that parents base formula choices not only on marketing claims but also on safety records, manufacturing standards, and FDA oversight.
The FDA plays a critical role in monitoring infant formula safety. Following outbreaks like the one linked to ByHeart, the agency investigates potential contamination, coordinates recalls, and issues public health alerts.
The ongoing investigation will determine whether stricter regulations or mandatory testing requirements are necessary to prevent future incidents. Meanwhile, federal and state health agencies continue to track infant botulism cases and provide guidance to parents.
The ByHeart outbreak highlights vulnerabilities in the U.S. infant formula supply chain. With only six companies producing the majority of formula in the United States, even minor contamination events can have widespread consequences.
Experts suggest that the industry may need to implement:
Adopting these measures could restore consumer confidence and reduce the risk of outbreaks affecting vulnerable infants.
The ByHeart infant formula botulism outbreak is a serious public health concern, reminding parents, healthcare providers, and policymakers of the importance of food safety in infant nutrition. While the FDA and ByHeart continue investigations, parents must remain vigilant, monitor for symptoms of infant botulism, and follow recall notices.
Infant formula provides essential nutrition for many babies, and outbreaks like this underscore the need for strict safety standards, comprehensive testing, and regulatory oversight. As investigations progress, families affected by the outbreak can seek medical care and legal support, while the industry evaluates lessons learned to prevent future incidents.
By staying informed and cautious, parents can protect their children while navigating the complexities of infant feeding choices.
Sources:
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice from a qualified healthcare professional for individual health concerns.
Most Accurate Healthcare AI designed for everything from admin workflows to clinical decision support.